Arsb Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| ARSB Gene | |
|---|---|
| Gene Symbol | ARSB |
| Full Name | Arylsulfatase B |
| Chromosomal Location | 5q14.1 |
| NCBI Gene ID | [409](https://www.ncbi.nlm.nih.gov/gene/409) |
| OMIM | [253200](https://www.omim.org/entry/253200) |
| Ensembl ID | ENSG00000113273 |
| UniProt ID | [P15884](https://www.uniprot.org/uniprot/P15884) |
| Associated Diseases | Mucopolysaccharidosis Type VI (MPS VI), Neurodegeneration |
The ARSB gene (Arylsulfatase B) encodes a lysosomal hydrolase enzyme that catalyzes the removal of sulfate groups from glycosaminoglycans (GAGs), particularly dermatan sulfate and chondroitin sulfate. This gene is essential for the degradation of these complex carbohydrates within lysosomes.
Arylsulfatase B is a member of the sulfatase family of enzymes. The enzyme hydrolyzes the sulfate ester bond at the non-reducing end of dermatan sulfate and chondroitin sulfate, playing a critical role in the lysosomal degradation pathway for glycosaminoglycans.
Also known as Maroteaux-Lamy syndrome, MPS VI is caused by autosomal recessive mutations in the ARSB gene, resulting in deficient or absent arylsulfatase B activity.
Clinical Features:
Inheritance Pattern: Autosomal recessive
While MPS VI is primarily a systemic disorder, neurological manifestations can include:
Expression data from the Allen Brain Atlas indicates moderate expression across multiple brain regions, with particular enrichment in cells with high lysosomal activity.
The study of Arsb Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.